Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia?
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Currently a dramatic increase in patients with end‐stage renal failure is seen world‐wide [1,2]. Furthermore, cardiovascular morbidity and mortality is exceedingly high in patients with chronic renal failure. Preventing progression of chronic renal failure and reducing cardiovascular complications in uraemia are major challenges to nephrologists. In the following we marshal evidence that sympathetic overactivity, so far a neglected aspect of renal failure, is an important pathomechanism contributing to progression and cardiovascular complications. It is possible that interventions to interfere with sympathetic overactivity will provide new therapeutic approaches. In chronic renal disease, the two most important progression factors which are susceptible to intervention are hypertension and proteinuria. In this respect research and therapy in the past focused mainly on interventions concerning the renin‐angiotensin‐system. Many controlled studies have demonstrated that ACE‐inhibitors, compared to placebo, attenuate the rate of progression of chronic renal failure. There is still debate whether the beneficial effect of ACE‐inhibition is fully explained by better control of blood pressure [3]. The sympathetic nervous system is known to be important for pathophysiology and prognosis of a variety of cardiovascular diseases including essential hypertension and chronic heart failure. For instance, the degree of sympathetic overactivity is a major predictor of survival in patients with a history of myocardial infarction and determines the risk of arrhythmia and sudden cardiac death [4]. It is therefore surprising that so far nephrologists have neglected the therapeutic potential of modulating sympathetic nervous activity in chronic renal failure. This is even more strange, since there is convincing evidence to show that in chronic renal failure sympathetic overactivity is substantially involved in the development of hypertension, progression of renal failure and cardiovascular prognosis. The available experimental and clinical evidence to suggest such a pathophysiological role of sympathetic overactivity is briefly summarized below. In 1992 Converse et al. [5] documented that in end‐stage renal failure sympathetic tone is increased. They measured sympathetic nerve activity using microneurography of the N. peronaeus and demonstrated an increased sympathetic firing rate even in the intradialytic interval suggesting that this finding was largely volume independent. The most surprising observation was that bilaterally nephrectomized patients had normal sympathetic drive—comparable to that of controls without renal failure. These patients also had lower blood pressure. The authors concluded that the diseased kidneys activate the sympathetic system. This could imply that the sympathetic nervous system plays an important role in renal disease—but what are the underlying mechanisms? The kidneys have a dense afferent sensory and efferent sympathetic innervation. Therefore, they can be origin as well as target of overactivity of the sympathetic nervous system (Figure 1). This has been shown convincingly in an animal model of chronic renal failure [6]. Subtotally nephrectomized rats develop a rapid increase of blood pressure within 1 week after renal ablation. In contrast, subtotally nephrectomised rats in which afferent sensory signals have been abrogated by section of the dorsal roots do not develop hypertension. This observation suggests, that afferent signals from the diseased kidneys are transmitted to the vasomotor control center in the brain and thereby increase blood pressure (Figure 1) at least in this model of chronic renal failure. Is this mechanism of any relevance for patients suffering from chronic renal failure? The answer seems to be yes! Ligtenberg and colleagues [7] used the same microneurographic technique and demonstrated that even patients who are not yet on dialysis had increased sympathetic nerve activity as well. What are the mechanisms in the kidney provoking afferent renal nerve traffic? It is conceivable that uraemic toxins act as irritants, but this possibility seems unlikely for various reasons. First, even after correction of uraemia by renal transplantation increased sympathetic nerve activity persists [8]. Second, even acute renal damage [9] and renal ischaemic disease [10,11], not associated with uraemia, lead to sympathetic activation and hypertension. Furthermore, increased noradrenaline secretion rates have been observed in patients with nephrotic syndrome [12] and in hypertensive autosomal dominant polycystic kidney disease [13] despite normal renal function. These results suggest that sympathetic overactivity is an early event in the pathophysiology of chronic renal failure and that renal damage of various aetiologies activates the sympathetic nervous system via afferent signal of sensory renal nerves (Figure 1). The resulting overactivity at the neuroeffector junction of peripheral organs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sympathetic Overactivity in Patients with Chronic Renal Failure
Converse, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M. T., Cosentino, F., Fouad-Tarazi, F., & Victor, R. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272704 · Cited by 1,132
Increased Sympathetic Nerve Activity in Renovascular Hypertension
Johansson, M., Elam, M., Rundqvist, B., Eisenhofer, G., Herlitz, H., Lambert, G., & Friberg, P. (1999) · Circulation · doi:10.1161/01.cir.99.19.2537 · Cited by 172
Cited by
Chronic kidney disease as cause of cardiovascular morbidity and mortality
Vanholder, R., Massy, Z., Argiles, A., Spasovski, G., Verbeke, F., & Lameire, N. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh813 · Cited by 613
Renal Denervation in Moderate to Severe CKD
Hering, D., Mahfoud, F., Walton, A. S., Krum, H., Lambert, G. W., Lambert, E. A., Sobotka, P. A., Böhm, M., Cremers, B., Esler, M. D., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011111062 · Cited by 361
Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics
Pun, P. H., Lehrich, R. W., Honeycutt, E. F., Herzog, C. A., & Middleton, J. P. (2011) · Kidney International · doi:10.1038/ki.2010.315 · Cited by 277
Suzuki, T., Agarwal, S. K., Deo, R., Sotoodehnia, N., Grams, M. E., Selvin, E., Calkins, H., Rosamond, W., Tomaselli, G., Coresh, J., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.07.004 · Cited by 38
Singh, R. R., McArdle, Z. M., Booth, L. C., May, C. N., Head, G. A., Moritz, K. M., Schlaich, M. P., & Denton, K. M. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16718 · Cited by 15
Metadata
- Authors
- Rump, L. C., Amann, K., Orth, S., & Ritz, E.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-11-01
- Volume
- 15
- Issue
- 11
- Pages
- 1735-1738
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2145264233
- Cited by
- 97
- References
- 2
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia? https://app.cochat.ai/papers/10.1093/ndt/15.11.1735
- The paper
- Rump, L. C., Amann, K., Orth, S., & Ritz, E. (2000). Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia? Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/15.11.1735
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.